Prices for Xarelto (rivaroxaban) in 2025 vary a lot by country, dosage, and whether you’re using the brand or a generic. I don’t have live pricing for your exact location, but here’s a quick, practical overview and how you can find the exact price:
- What drives the price
- Country and health system (national vs private pricing)
- Brand name vs generic rivaroxaban (generics can be much cheaper where available)
- Dose and supply size (e.g., 15 mg vs 20 mg tablets, 30-day supply)
- Insurance coverage and patient assistance programs
- Rough ballparks (to give you an idea)
- United States (brand Xarelto): Typical monthly costs for a 30-day supply of common doses can be several hundred dollars before insurance (roughly in the ballpark of $500–$700 for a month without insurance). With insurance or coupons, out-of-pocket can be much lower.
- Other high-income markets with price controls or managed care: Brand prices are often lower than in the US, and generics (where available) can substantially reduce cost.
- Markets with national health coverage: Out-of-pocket costs are usually lower, and many patients pay a fixed copay or get the medicine covered.
- What to do to get an exact price now
- Tell me your country and whether you want brand or generic rivaroxaban, plus the exact dose (e.g., 15 mg or 20 mg) and how many tablets you’d get per month.
- I can give you a more targeted price range and point you to local resources (pharmacy price lookups, discount programs, or patient assistance).
- For the US specifically, you can check:
- Your pharmacy’s cash price (call or use their app)
- Coupon/discount sites (e.g., GoodRx)
- The manufacturer’s patient assistance programs (if you’re uninsured or have high costs)
- If you’re in Europe/Canada/UK, I can tailor advice to typical local processes (e.g., NHS coverage, provincial pricing, or private-pay options).
If you share your country, dosage, and whether you want brand or generic, I’ll give you a clearer, locally relevant estimate and tips to save on cost. Also, if cost is a concern, I can discuss potential alternatives or patient-aid options with your clinician.